News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eleven Biotherapeutics (EBIO) To Present At Upcoming Ophthalmology Industry Conferences


4/21/2014 6:35:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that it will be presenting at three ophthalmology industry conferences in the coming weeks. Eleven will participate in a discussion with experts on dry eye disease and will review Phase 1b/2a clinical data on its lead drug candidate EBI-005 for dry eye disease and preclinical data on EBI-029 for diabetic macular edema.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES